Rayner launches T-flex lens

Article

Rayner Intraocular Lenses Limited has globally launched its T-flex Aspheric toric IOL.

Rayner Intraocular Lenses Limited has globally launched its T-flex Aspheric toric IOL.

The aspheric optics are aberration-neutral for increased contrast sensitivity and depth of field and the T-flex Aspheric IOL is designed to deliver uniform refractive power from the centre of the optic to the edge, for optimal visual outcomes.At the same time, Rayner has also extended the T-flex Aspheric standard range which will now encompass +1.0D to +6.0D in 0.5D increments as opposed to the original 1.0D increments.

“Within the industry, Rayner has the most extensive range of IOLs for astigmatic correction with the T-flex Aspheric, M-flex T and Sulcoflex Toric ranges. T-flex is a further and significant enhancement of our toric IOL product offering to ophthalmic surgeons worldwide and one that helps us keep ahead of the game in this important segment of the IOL market,” says Donald Munro, managing director and chairman of Rayner Intraocular Lenses Limited.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.